195 related articles for article (PubMed ID: 36940080)
1. Enlarged pore of worm mesoporous silica nanoparticles improves anti-inflammatory drug absorption.
Ou Y; Zhu D
Drug Deliv Transl Res; 2023 Oct; 13(10):2475-2486. PubMed ID: 36940080
[TBL] [Abstract][Full Text] [Related]
2. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
[TBL] [Abstract][Full Text] [Related]
3. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
Zhu Y; Wang B; Chen J; He J; Qiu X
Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
[TBL] [Abstract][Full Text] [Related]
4. Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect.
Guo Y; Gou K; Yang B; Wang Y; Pu X; Li S; Li H
Molecules; 2019 Sep; 24(19):. PubMed ID: 31575047
[TBL] [Abstract][Full Text] [Related]
5. Concealed body mesoporous silica nanoparticles for orally delivering indometacin with chiral recognition function.
Zhou J; Zhu F; Li J; Wang Y
Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():314-324. PubMed ID: 29853097
[TBL] [Abstract][Full Text] [Related]
6. Mesoporous Carbon Nanoparticles as Multi-functional Carriers for Cancer Therapy Compared with Mesoporous Silica Nanoparticles.
Zhou M; Zhao Q; Wu Y; Feng S; Wang D; Zhang Y; Wang S
AAPS PharmSciTech; 2020 Jan; 21(2):42. PubMed ID: 31897882
[TBL] [Abstract][Full Text] [Related]
7. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system.
Yu F; Wu H; Tang Y; Xu Y; Qian X; Zhu W
Int J Pharm; 2018 Jan; 536(1):11-20. PubMed ID: 29146540
[TBL] [Abstract][Full Text] [Related]
8. Development of Mesoporous Silica Nanoparticles of Tunable Pore Diameter for Superior Gemcitabine Drug Delivery in Pancreatic Cancer Cells.
Saini K; Prabhuraj RS; Bandyopadhyaya R
J Nanosci Nanotechnol; 2020 May; 20(5):3084-3096. PubMed ID: 31635652
[TBL] [Abstract][Full Text] [Related]
9. Exploring the role of mesoporous silica nanoparticle in the development of novel drug delivery systems.
Stephen S; Gorain B; Choudhury H; Chatterjee B
Drug Deliv Transl Res; 2022 Jan; 12(1):105-123. PubMed ID: 33604837
[TBL] [Abstract][Full Text] [Related]
10. Control-release microcapsule of famotidine loaded biomimetic synthesized mesoporous silica nanoparticles: Controlled release effect and enhanced stomach adhesion in vitro.
Li J; Wang H; Yang B; Xu L; Zheng N; Chen H; Li S
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():273-7. PubMed ID: 26478311
[TBL] [Abstract][Full Text] [Related]
11. Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging.
Croissant JG; Zhang D; Alsaiari S; Lu J; Deng L; Tamanoi F; AlMalik AM; Zink JI; Khashab NM
J Control Release; 2016 May; 229():183-191. PubMed ID: 27016140
[TBL] [Abstract][Full Text] [Related]
12. Optimized mesoporous silica nanoparticle-based drug delivery system with removable manganese oxide gatekeeper for controlled delivery of doxorubicin.
Miao Y; Feng Y; Bai J; Liu Z; Zhao X
J Colloid Interface Sci; 2021 Jun; 592():227-236. PubMed ID: 33662827
[TBL] [Abstract][Full Text] [Related]
13. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.
He Y; Luo L; Liang S; Long M; Xu H
J Biomater Appl; 2017 Oct; 32(4):524-532. PubMed ID: 28776488
[TBL] [Abstract][Full Text] [Related]
14. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells.
Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A
Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642
[TBL] [Abstract][Full Text] [Related]
15. Ionic and thermo-switchable polymer-masked mesoporous silica drug-nanocarrier: High drug loading capacity at 10°C and fast drug release completion at 40°C.
Eltohamy M; Seo JW; Hwang JY; Jang WC; Kim HW; Shin US
Colloids Surf B Biointerfaces; 2016 Aug; 144():229-237. PubMed ID: 27092438
[TBL] [Abstract][Full Text] [Related]
16. Smart MSN-Drug-Delivery System for Tumor Cell Targeting and Tumor Microenvironment Release.
Dong JH; Ma Y; Li R; Zhang WT; Zhang MQ; Meng FN; Ding K; Jiang HT; Gong YK
ACS Appl Mater Interfaces; 2021 Sep; 13(36):42522-42532. PubMed ID: 34463488
[TBL] [Abstract][Full Text] [Related]
17. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
18. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
[TBL] [Abstract][Full Text] [Related]
20. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
